3 Biggest Biotech Crashes in March
Here's why Celldex (CLDX), Acceleron (XLRN), and Newlink (NLNK) all tumbled in March.
Why Tesla Motors, Acceleron Pharma, and Ballard Power Systems Jumped Today
The Dow finished just below its all-time highs, but the market's overall gains were small compared to these three stocks. Find out more about what made them soar.
What You Ought To Know About Celgene's Deal-Making Magic
Celgene's investment team has made a string of savvy investments in early stage biotech companies.